+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Epstein-Barr virus-related post transplant lymphoproliferative disease of donor origin in two orthotopic liver transplant recipients



Epstein-Barr virus-related post transplant lymphoproliferative disease of donor origin in two orthotopic liver transplant recipients



Hepatology 22(4 Part 2): 210A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031279833

Download citation: RISBibTeXText


Related references

Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients. Journal Of Hepatology. 26(4): 926-934, 1997

Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases. Transplant Infectious Disease 7(3-4): 133-136, 2006

EBNA 1 and BZLF1 plus IgG serum levels individuate early stages of Epstein Barr virus -related post transplant lymphoproliferative disease and helps modulation of immune suppression in liver transplant recipients. Hepatology 28(4 Part 2): 268A, 1998

Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease. American Journal of Transplantation 5(3): 566-572, 2005

Factors associated with the development of post-transplant lymphoproliferative disease (PTLD) in Epstein-Barr virus (EBV)-seronegative adult liver transplant recipients. Transplant International 7(Suppl. 1): S235-S237, 1994

Factors associated with the development of post-transplant lymphoproliferative disease (PTLD) in Epstein-Barr virus (EBV) - seronegative adult liver transplant recipients. Transplant International 7(Suppl. S1): 235-237, 1994

Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplant recipients, 1988-97: a Canadian multi-centre experience. Pediatric Transplantation 5(3): 198-203, 2001

Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients. Nephrology Dialysis Transplantation 27(7): 2971-2979, 2012

Low incidence of Epstein-Barr virus-associated post-transplant lymphoproliferative disorders in 263 unrelated donor umbilical cord blood transplant recipients. Blood 96(11 Part 1): 206a, 2000

Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients. Clinical Microbiology and Infection 20(Suppl. 7): 109-118, 2014

Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders in Cystic Fibrosis Lung Transplant Recipients: A Case Series. Transplantation Proceedings 51(1): 194-197, 2019

Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease. Journal of Medical Virology 69(2): 258-266, 2003

The use of objective case ascertainment to identify risk factors for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder in pediatric liver transplant recipients. Hepatology 36(4 Part 2): 662A, 2002

Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients. Clinical Transplantation 20(3): 389-393, 2006

The role of real-time PCR assay for prevention of Epstein-Barr virus-associated post-transplant lymphoproliferative disease in renal transplant recipients. Journal of Urology 165(5 Suppl.): 385, 2001